Long-Term Outcomes of Hip Interventions for Children With Cerebral Palsy
CHOP II
1 other identifier
observational
1,000
1 country
1
Brief Summary
Children with severe cerebral palsy (CP) are at high risk for progressive hip displacement, associated with pain and contractures interfering with many aspects of care, comfort and quality of life. These children undergo many types of interventions, the optimal timing and effectiveness of which, remain unclear. In 2014, CIHR funded the CP Hip Outcomes Project (CHOP), an international multi-centre prospective longitudinal cohort study of children with severe (non-ambulant) CP with evidence of hip displacement defined as a Reimer's migration percentage (MP) of at least 30%. The study was designed to evaluate the comparative effectiveness of different treatment strategies to prevent or relieve symptoms associated with hip instability, using the validated Caregiver Priorities and Child Health Index of Life with Disabilities (CPCHILD ) questionnaire as the primary outcome measure of health-related quality of life © (HRQL) for this population. 650 patients enrolled from 28 sites in 11 countries, are actively being followed and will reach at least 2 years of follow-up at the end of 2019. This project, will study the impact of hip instability and its management in children with severe CP using the CPCHILD questionnaire that was developed specifically for this purpose. Although CHOP will define outcomes at 24 months, the outcomes are not expected to remain stable while the child is still growing. The inception cohort will need follow-up until skeletal maturity to track their long-term outcome trajectories.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2019
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2019
CompletedFirst Submitted
Initial submission to the registry
March 8, 2021
CompletedFirst Posted
Study publicly available on registry
March 11, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 31, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2028
ExpectedMarch 11, 2021
March 1, 2021
6.5 years
March 8, 2021
March 8, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Caregiver Priorities & Child Health Index of Life with Disabilities (CPCHILD)
The CPCHILD questionnaire is intended for persons with CP who rely on a wheelchair for most of their mobility. The CPCHILD questionnaire assesses how parents or caregivers rate their child (or how a child rates him/herself when able) about various issues related to daily activities, self care, getting around, comfort, communication, social interaction and health. The CPCHILD also identifies which of these issues the parents (or the child) feel are important to improve.
The CPCHILD takes approximately 15 minutes to complete
Study Arms (5)
"Natural" History or watchful waiting
Serial botulinum toxin injections
Adductor (+/- psoas) muscle releases alone
Hip reconstructive surgery
Salvage hip surgery
Eligibility Criteria
Children between the ages of 2 and 19 with severe cerebral palsy (defined as a GMFCS level or IV or V) experiencing hip displacement (with radiographic evidence of a migration percentage (MP) or 30%) will be recruited to be apart of the CHOP II study.
You may qualify if:
- Children with severe, non-ambulant (GMFCS IV \& V) Cerebral Palsy
- between 2 and 19 years of age
- with radiographic evidence of hip displacement (previously untreated) as measured by Reimer's MP ≥ 30%
- and their parents or primary caregivers, defined as the individual most involved in the daily care of the child are willing to complete the CPCHILD in one of the available languages the CPCHILD is offered in
You may not qualify if:
- under the age of 2, or over the age of 19
- Reimer's migration percentage under 30% in both hips
- parents or primary caregivers unable to complete the CPCHILD in one of it's available languages
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- The Hospital for Sick Childrenlead
- Royal Children's Hospitalcollaborator
- Shriners Hospitals for Children,Canadacollaborator
- Provincial Health Services Authority British Columbiacollaborator
- Aarhus University Hospitalcollaborator
- Sheba Medical Centercollaborator
- Seoul National University Bundang Hospitalcollaborator
- Starship Children's Hospital of New Zealandcollaborator
- Poznan University of Medical Sciencescollaborator
- Skane University Hospitalcollaborator
- Karolinska University Hospitalcollaborator
- Great Ormond Street Hospital for Children NHS Foundation Trustcollaborator
- The Royal London Hospitalcollaborator
- Nuffield Orthopaedic Centre NHS Trustcollaborator
- Children's Hospital Medical Center, Cincinnaticollaborator
- Boston Children's Hospitalcollaborator
- Columbia Universitycollaborator
- Shriners Hospitals for Children, Sacramentocollaborator
- Gillette Children's Specialty Healthcarecollaborator
- Alfred I. duPont Hospital for Childrencollaborator
- IWK Health Centrecollaborator
- Alder Hey Children's NHS Foundation Trustcollaborator
- Children's Hospital Coloradocollaborator
- Hospital for Special Surgery, New Yorkcollaborator
- Shriners Hospitals for Children, Honolulucollaborator
- Robert Jones and Agnes Hunt Orthopaedic and District NHS Trustcollaborator
- Morgan Stanley Children's Hospitalcollaborator
- Children's Health Queensland Hospital and Health Servicecollaborator
- University of Nebraskacollaborator
Study Sites (1)
The Hospital for Sick Children
Toronto, Ontario, M5G 1X8, Canada
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Unni G Narayanan
The Hospital for Sick Children
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MBBS, MSc, FRSC(C)
Study Record Dates
First Submitted
March 8, 2021
First Posted
March 11, 2021
Study Start
October 1, 2019
Primary Completion
March 31, 2026
Study Completion (Estimated)
March 31, 2028
Last Updated
March 11, 2021
Record last verified: 2021-03
Data Sharing
- IPD Sharing
- Will not share